The chemotherapy of rodent malaria. LVII. Drug combinations to impede the selection of drug resistance, part 1: Which model is appropriate?

Annals of Tropical Medicine and Parasitology

Volumn 93, Issue 6, 1999, Pages 569-587

  Peters, W ^a  

^a CABI   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; CYCLOGUANIL; DAPSONE; FANSIDAR; MEFLOQUINE; MEPACRINE; PYRIMETHAMINE; PYRONARIDINE; SULFADOXINE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINATION CHEMOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MALARIA; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIMALARIALS; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MICE; PLASMODIUM BERGHEI; PLASMODIUM YOELII; RODENT DISEASES;

ANIMALIA; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PROTOZOA; RODENTIA;

EID: 0032869136     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034989958087     Document Type: Article

References (47)

1. CHEN, C., CAI, X.-Z., CHE, L.-G., CHEN, H.-L. & JIANG, M.-G. (1997). Analysis on results of antimalarial pyronaridine combined with sulfadoxine and pyrimethamine to falciparum malaria. Journal of Practical Parasitic Disease, 5, 104-107 (in Chinese, with English abstract).
2. CURTIS, C. F. & OTOO, L. N. (1986). A simple model of the build-up of resistance to mixtures of anti-malarials. Transaction of the Royal Society of Tropical Medicine and Hygiene, 80, 889-892.
3. DIGGENS, S. M., GUTTERIDGE, W. E. & TRIGG, P. I. (1970). Altered dihydrofolate reductase associated with a pyrimethamine resistant Plasmodium berghei berghei produced in a single step. Nature, 228, 579-580.
4. DYE, C. & WILLIAMS, B. G. (1097). Multigenic drug resistance among inbred malaria parasites. Proceedings of the Royal Society of London, Series B, 264, 61-67.
5. FU, S. & XIAO, S.-H. (1991). Pyronaridine: a new antimalarial drug. Parasitology Today, 7, 310-313.
6. LIU, D., LIU, R., ZHANG, C., CAI, X., TANG, X., YANG, H., YANG, P. & DONG, Y. (1996). Present status of the sensitivity of Plasmodium falciparum to antimalarials in China. Chinese Journal of Parasitology and Parasitic Diseases, 14, 37-41.
7. MERKLI, B. & RICHLE, R. W. (1980). Studies on the resistance to single and combined antimalarials in the Plasmodium berghei mouse model. Acta Tropica, 37, 228-231.
8. MERKLI, B., RICHLE, R. W. & PETERS, W. (1980). The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei. Annals of Tropical Medicine and Parasitologo, 74, 1-9.
9. PETERS, W. (1965a). Drug resistance in Plasmodium berghei (Vincke and Lips 1948). I. Chloroquine resistance. Experimental Parasitology, 17, 80-89.
10. PETERS, W. (1965b). Mepacrine- and primaquine-resistant strains of Plasmodium berghei (Vincke and Lips 1948). Nature, 208, 693-694.
11. PETERS, W. (1965c). Morphological and physiological variations in chloroquine-resistant Plasmodium berghei (Vincke and Lips 1948). Annales de la Société Belge de Médecine Tropicale, 45, 365-378.
12. PETERS, W. (1969). Partial inhibition by mepacrine of the development of sulphonamide resistance in Plasmodium berghei. Nature, 223, 858-859.
13. PETERS, W. (1974). Prevention of drug resistance in rodent malaria by the use of drug mixtures. Bulletin of the World Health Organization, 51, 379-383.
14. PETERS, W. (1987). Chemotherapy and Drug Resistance in Malaria, 2nd Edn. London: Academic Press.
15. PETERS, W. (1998). Drug resistance in malaria parasites of animals and man. Recent Advances in Parasitology, 41, 1-62.
16. PETERS, W. & ROBINSON, B. L. (1984). The chemotherapy of rodent malaria. XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'. Annals of Tropical Medicine and Parasitology, 78, 459-466.
17. PETERS, W. & ROBINSON, B. L. (1999). The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides. Annals of Tropical Medicine and Parasitology, 93, 325-339.
18. PETERS, W., PORTUS, J. H. & ROBINSON, B. L. (1973). The chemotherapy of rodent malaria. XVII. Dynamics of drug resistance, part 3: influence of drug combinations on the development of resistance to chloroquine in P. berghei. Annals of Tropical Medicine and Parasitology, 67, 143-154.
19. PETERS, W., PORTUS, J. H. & ROBINSON, B. L. (1975). The chemotherapy of rodent malaria. XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity. Annals of Tropical Medicine and Parasitology, 69, 155-171.
20. PETERS, W., PORTUS, J.H. & ROBINSON, B. L. (1977). The chemotherapy of rodent malaria. XXVIII. The development of resistance to mefloquine (WR 142,490). Annals of Tropical Medicine and Parasitology, 71, 419-427.
21. PETERS, W., CHANCE, M., LISSNER, R., MOMEN, H. & WARHURST, D. C. (1978). The chemotherapy of rodent malaria. XXX. The enigmas of the 'NS' lines of P. berghei. Annals of Tropical Medicine and Parasitology, 72, 23-36.
22. PLATEL, D. F., MANGOU, F. & TRIBOULEY DURET, J. (1998). High-level chloroquine resistance of Plasmodium berghei is associated with multiple drug resistance and loss of reversal by calcium antagonists. International Journal for Parasitology, 28, 641-651.
23. PURI, S. K. & DUTTA, G. P. (1989). Delay in emergence of mefloquine resistance in Plasmodium berghei by use of drug combinations. Acta Tropica, 46, 209-212.
24. RAMAKRISHNAN, S. P., PRAKASH, S., CHOUDHURY, D. A. & BASU, P. C. (1961). Studies on Plasmodium berghei (Vincke and Lips 1948). XXIX. The size of parasite population and its relation to the selection of a strain resistant to sulphadiazine. Indian Journal of Malariology, 13, 95-106.
25. SCHMIDT, L. H. & ROSSAN, R. N. (1984). Activities of repository preparations of cycloguanil pamoate and 4,4′-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys. Antimicrobial Agents and Chemotherapy, 26, 611-642.
26. SHAO, B. R. & YE, X. Y. (1986). Delay in emergence of resistance to pyronaridine phosphate in Plasmodium berghei. Acta Pharmacologica Sinica, 7, 463-467.
27. SHAO, B. R., YE, X. Y. & ZHENG, H. (1982). Development of pyronaridine resistance in Plasmodium berghei. Acta Pharmaceutica Sinica, 17, 566-571.
28. SHAO, B. R., HUANG, Z.-S., SHI, X.-H. & MENG, F. (1991). A 5-year surveillance of sensitivity in vivo of Plasmodium falciparum to pyronaridine/sulfadoxine/pyrimethamine in Diaoluo area, Hainan province. Southeast Asian Journal of Tropical Medicine and Public Health, 22, 65-67.
29. SHI, X. H. (1988). Efficacy of pyronaridine/sulfadoxine/pyrimethamine on Plasmodium berghei-infected mice. Thesis, Institute of Parasitic Diseases, Academy of Preventive Medicine, Shanghai.
30. SHULMAN, C. E., DORMAN, E. K., CUTTS, F., KAWUONDO, K., BULMER, J. N., PESHU, N. & MARSH, K. (1999). Intermittent sulphadoxine pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet, i, 632-636.
31. TAN-ARIYA, P., BROCKELMAN, C. R. & MENABANDHU, C. (1984). Mefloquine-pyrimethamine-sulfadoxine combination delays emergence of mefloquine resistant Plasmodium falciparum in continuous culture. Southeast Asian Journal of Tropical Medicine and Public Health, 15, 531-535.
32. THOMPSON, P. E., BAYLES, A., OLSZEWSKI, B. & WAITZ, J. A. (1965). Studies on a dihydrotriazine and a sulfone, alone and in combination, against Plasmodium berghei in mice. American Journal of Tropical Medicine and Hygiene, 14, 198-206.
33. VON SEIDLEIN, L., BOJANG, K., JONES, P., JAFFAR, S., PINDER, M., OBARO, S., DOHERTY, T., HAYWOOD, M., SNOUNOU, G., GEMPERLI, B., GATHMANN, I., ROYCE, C., MCADAM, K. & GREENWOOD, B. (1998). A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. American Journal of Tropical Medicine and Hygiene, 58, 638-644.
34. WATKINS, W. M. & MOSOBO, M. (1993). Treatment of Plasmodium falciparum malaria with PSD: selective pressure for resistance is a function of long elimination half life. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 75-78.
35. WATKINS, W. M., MBERU, E. K., WINSTANLEY, P. A. & PLOWE, C. V. (1997). The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. Parasitology Today, 13, 459-464.
36. WERNSDORFER, W, (Ed.) (1982). Drag-resistant Malaria. The Report of a Meeting Held in Kuala Lumpur, Malaysia 10-15 August 1981. Geneva: World Health Organization.
37. WERNSDORFER, W. H. & PAYNE, D. (1991). The dynamics of drug resistance in Plasmodium falciparum. Pharmacology and Therapeutics, 50, 95-121.
38. WHITE, N. J. (1992). Antimalarial drug resistance: the pace quickens. Journal of Antimicrobial Chemotherapy, 30, 571-585.
39. WHITE, N. J. (1997). Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrobial Agents and Chemotherapy, 41, 1413-1422.
40. WHITE, N. J. (1998). Preventing antimalarial drug resistance through combinations. Drug Resistance Updates, 1, 3-9.
41. WHITE, N. J. & OLLIARO, P. L. (1996). Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitology Today, 12, 399-401.
42. WORLD HEALTH ORGANIZATION (1961). Chemotherapy of Malaria. Report of a Technical Meeting. Technical Report Series No. 226. Geneva: WHO.
43. WORLD HEALTH ORGANIZATION (1965). Resistance of Malaria Parasites to Drugs. Technical Report Series No. 296. Geneva: WHO.
44. WORLD HEALTH ORGANIZATION (1967). Chemotherapy of Malaria. Report of a WHO Scientific Group. Technical Report Series No. 375. Geneva: WHO.
45. WORLD HEALTH ORGANIZATION (1973). Chemotherapy of Malaria and Resistance to Antimalarials. Report of a WHO ScientIfic Group. Technical Report Series No. 529. Geneva: WHO.
46. WORLD HEALTH ORGANIZATION (1983). Development of mefloquine as an antimalarial drug. Bulletin of the World Health Organization, 61, 169-178.
47. WORLD HEALTH ORGANIZATION (1984). Advances in Malaria Chemotherapy. Report of a WHO Scientific, Group. Technical Report Series No. 711. Geneva: WHO.